Patent · US Expired

Clinical use of somatostatin analogues

US4612302A · kind A · utility

65Cited by

9References

21Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Sandor Szabo · Elmwood Park, US
Klaus W. Usadel · Weinheim, DE
Horst Kessler · Schwalbach, DE

Key dates

Filing date	Nov 14, 1983
Grant date	Sep 16, 1986
Priority date	—
Expiry date	Nov 14, 2003

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S930/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of increasing the clearance of particles from the blood stream of a vertebrate, which comprises administering to a vertebrate having a surplus of particles in the blood stream of the vertebrate an amount of a somatostatin analogue sufficient to increase phagocytosis in the vertebrate is disclosed along with a method treating vascular lesions or deterioration of biological membranes comprising the step of administering to a human or other mammal suspected of having one or more vascular lesions or of having deterioration of a biological membrane in the liver of said human or mammal an amount of a somatostatin analogue sufficient to reduce the number or severity of said lesions or to prevent further deterioration or reduce the extent of deterioration of said membrane.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.